Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
| Status: | Completed |
|---|---|
| Conditions: | Other Indications, Pain, Urology, Urology |
| Therapuetic Areas: | Musculoskeletal, Nephrology / Urology, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/20/2018 |
| Start Date: | August 2007 |
| End Date: | April 2008 |
URG101 Pharmacodynamic and Safety Study: A Randomized, Double-blind, Placebo-controlled, Multi-center Cross-over Study to Investigate the Pharmacodynamic Profile of URG101 in Subjects With Pelvic Pain of Bladder Origin.
A double-blind, placebo-controlled study to evaluate changes in pain, urgency and urinary
frequency following administration of URG101 compared to placebo.
frequency following administration of URG101 compared to placebo.
Inclusion Criteria:
- male and female subjects >= 18 years of age
- moderate to severe symptoms of PBS/IC
- minimum pain/urgency/frequency scores
- female subjects on hormone therapy must be on stable dose for >= 3 months
Exclusion Criteria:
- positive pregnancy test or pregnant or lactating
- narcotics or medical marijuana within 3 months
- use of any investigational drug or device within 30 days
- bacterial cystitis within 30 days
We found this trial at
6
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials